Physician profile
Wallace Lai
NPI 1578503249
$7,719.97
in general payments reported to CMS, 2019-2025
31 companies · $375 in 2025
The $375 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $677 · 2020: $320 · 2021: $506 · 2022: $5,177 · 2023: $172 · 2024: $494 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $4,875.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $618.12 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $327.91 | 2019-2022 | |
| Boston Scientific Corporation | $226.30 | 2019-2023 | Watchman Access System |
| Medtronic, INC. | $185.55 | 2021-2025 | Hawkone, Venaseal |
| Bard Peripheral Vascular, INC. | $184.15 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $182.41 | 2019-2023 | Eliquis |
| Merck Sharp & Dohme LLC | $157.74 | 2021-2022 | |
| Edwards Lifesciences Corporation | $126.69 | 2024 | |
| Amarin Pharma, INC. | $126.05 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $109.04 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $58.25 | 2024 | Optimizer |
| Lemaitre Vascular, INC. | $53.87 | 2020-2021 | |
| Amgen INC. | $47.84 | 2019-2025 | Repatha |
| Kci USA, INC. | $45.98 | 2020-2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $44.05 | 2021-2022 | |
| Tactile Systems Technology INC | $41.48 | 2020-2024 | Entre Plus, Flexitouch Plus |
| Inspire Medical Systems, INC. | $33.36 | 2024-2025 | Inspire |
| Cardinal Health 200 LLC | $29.96 | 2019-2020 | |
| Terumo Medical Corporation | $29.56 | 2019 | |
| Medtronic Vascular, INC. | $27.62 | 2019 | |
| Cardiovascular Systems INC. | $23.60 | 2019 | |
| Cmp Pharma, INC. | $22.82 | 2022 | |
| Teleflex LLC | $21.18 | 2021 | |
| Pfizer INC. | $21.12 | 2025 | |
| Inari Medical, INC. | $20.69 | 2019 | |
| Baxter Healthcare | $19.25 | 2021 | |
| Acera Surgical, INC. | $16.88 | 2019 | |
| Covidien Lp | $15.80 | 2019 | |
| Cordis US Corp. | $15.23 | 2021 | |
| Abbott Laboratories | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wallace Lai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.